Investors Research Corp’s Exact Sciences EXAS Stock Holding History

Investors Research Corp’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-104	Closed	-$7.05K	–	1098
2023 Q1	$7.05K	Hold	104	–	–	﹤0.01%	826
2022 Q4	$5.15K	Hold	104	–	–	﹤0.01%	872
2022 Q3	$3K	Hold	104	–	–	﹤0.01%	920
2022 Q2	$4K	Hold	104	–	–	﹤0.01%	862
2022 Q1	$7K	Hold	104	–	–	﹤0.01%	801
2021 Q4	$8K	Hold	104	–	–	﹤0.01%	797
2021 Q3	$10K	Hold	104	–	–	﹤0.01%	775
2021 Q2	$13K	Hold	104	–	–	﹤0.01%	733
2021 Q1	$14K	Hold	104	–	–	0.01%	729
2020 Q4	$14K	Hold	104	–	–	0.01%	797
2020 Q3	$11K	Hold	104	–	–	0.01%	801
2020 Q2	$9K	Hold	104	–	–	﹤0.01%	816
2020 Q1	$6K	Hold	104	–	–	﹤0.01%	860
2019 Q4	$10K	Hold	104	–	–	﹤0.01%	842
2019 Q3	$9K	Buy	+104	New	+$11.8K	﹤0.01%	857

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Investors Research Corp's EXAS Position: Q2 2023 in Review

Investors Research Corp sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 104 shares — an estimated $7.05K sold.

Investors Research Corp first reported a position in EXAS in Q3 2019 and held it in 15 quarters. The position peaked at $14K in Q1 2021. 654 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

Investors Research Corp reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
Investors Research Corp sold 104 Exact Sciences shares in Q2 2023, an estimated $7.05K.
Investors Research Corp first reported a position in Exact Sciences in Q3 2019 and held it in 15 quarters.
Investors Research Corp's Exact Sciences position peaked at $14K in Q1 2021.
654 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Investors Research Corp's 13F filing for Q2 2023, filed 14 Aug 2023.